Some of the biggest pharma giants are coming together to drive the surge in the development of the next generation of antibodies. A new study on the monoclonal antibody therapy is one step closer to treating rare diseases. Analysts predict breakthroughs and research within this market will increase revenues to $140 billion in 2022.  

The US alone invests approximately $45 billion annually within the drug industry with the majority of research in biologics. Overall, the global pharmaceutical market at US$934.8 billion is predicted to be US$1.17trillion in 2021 thanks to innovate studies catalysed by R&D incentives.

Being so innovative and relying heavily on research and development, the pharmaceutical industry is closely intertwined with many discovery platforms including but not limited to:

• Environmental Science
• Physiology
• Natural Science

Are you at the forefront of innovation?

Your company may be eligible for R&D Tax Credit, click here to find out more on how Swanson Reed can help.